Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Channing J Paller

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Drug Design, Development and Therapy|March 31, 2011
Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancerChanning J Paller, Emmanuel S Antonarakis
Oncology (Williston Park, N.Y.)|December 15, 2010
Youth has no age: cancer treatment for older AmericansChanning J Paller, Charles M Rudin
Human Vaccines & Immunotherapeutics|February 17, 2012
Sipuleucel-T for the treatment of metastatic prostate cancer: promise and challengesChanning J Paller, Emmanuel S Antonarakis
Journal of the National Cancer Institute|May 8, 2021
The Realities of Prostate Cancer Screening, Treatment, and RaceOtis W Brawley, Channing J Paller
Clinical Advances in Hematology & Oncology : H&O|February 19, 2013
Management of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directionsChanning J Paller, Emmanuel S Antonarakis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2019
Progress in the Systemic Management of Advanced Prostate Cancer: The Hormone-Sensitive ParadigmChanning J Paller, Mario A Eisenberger
The Oncologist|June 23, 2012
Finasteride and prostate cancer: a commentaryChanning J Paller, Thomas J Smith
Journal of the National Cancer Institute|June 24, 2020
Overdiagnosis in the Age of Digital Cancer ScreeningOtis W Brawley, Channing J Paller
JAMA Oncology|May 13, 2021
Considerations Regarding a Network Meta-analysis of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer-ReplyLin Wang, Channing J Paller, Hwanhee Hong
Urologic Oncology|January 10, 2025
Harnessing nature's therapeutic potential: A review of natural products in prostate cancer managementNicole A Metri, Adel Mandl, Channing J Paller
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Drug Design, Development and Therapy|March 31, 2011
Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancerChanning J Paller, Emmanuel S Antonarakis
Oncology (Williston Park, N.Y.)|December 15, 2010
Youth has no age: cancer treatment for older AmericansChanning J Paller, Charles M Rudin
Human Vaccines & Immunotherapeutics|February 17, 2012
Sipuleucel-T for the treatment of metastatic prostate cancer: promise and challengesChanning J Paller, Emmanuel S Antonarakis
Journal of the National Cancer Institute|May 8, 2021
The Realities of Prostate Cancer Screening, Treatment, and RaceOtis W Brawley, Channing J Paller
Clinical Advances in Hematology & Oncology : H&O|February 19, 2013
Management of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directionsChanning J Paller, Emmanuel S Antonarakis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2019
Progress in the Systemic Management of Advanced Prostate Cancer: The Hormone-Sensitive ParadigmChanning J Paller, Mario A Eisenberger
The Oncologist|June 23, 2012
Finasteride and prostate cancer: a commentaryChanning J Paller, Thomas J Smith
Journal of the National Cancer Institute|June 24, 2020
Overdiagnosis in the Age of Digital Cancer ScreeningOtis W Brawley, Channing J Paller
JAMA Oncology|May 13, 2021
Considerations Regarding a Network Meta-analysis of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer-ReplyLin Wang, Channing J Paller, Hwanhee Hong
Urologic Oncology|January 10, 2025
Harnessing nature's therapeutic potential: A review of natural products in prostate cancer managementNicole A Metri, Adel Mandl, Channing J Paller
Pageof 13